Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Discover whether oral medications for gestational diabetes cost less than insulin, based on SUGAR-DIP trial findings on expenses and safety.
Read More »Gestational Diabetes Treatment Has a Price Tag: Do Pills or Insulin Cost Less Overall?
Start With the Patient, Not the A1C: What Happens When Visits Ask “What Matters Most?”
What can the QBSafe trial teach us about person-centered diabetes care? Explore its findings on A1C, medication adherence, and patient priorities.
Read More »Can Better Self-Management Protect the Kidneys Before Damage Takes Hold?
Can better diabetes self-management protect kidney health? Explore new trial findings on A1C, blood pressure, cholesterol, and kidney function.
Read More »When Antibiotics Aren’t Enough: Phage Therapy Takes on Diabetic Foot Infections
Discover how BX211 bacteriophage therapy may improve diabetic foot ulcer healing, what Phase 2 trial results reveal, and why further research is needed.
Read More »Could a Saliva Test Replace the Glucose Drink in Pregnancy? The Science Isn’t There Yet
Can saliva tests detect gestational diabetes? Explore promising salivary biomarkers, new research findings, and why blood tests remain essential.
Read More »Shine a Light on Diabetic Nerve Pain? A Sham-Controlled Trial Tests the Idea
Can laser therapy relieve diabetic neuropathy pain? Explore new clinical trial findings, treatment benefits, limitations, and what patients should know.
Read More »One Molecular Switch, Two Organs: A New Clue to Type 2 Diabetes
Discover how CA8 may influence liver glucose production and pancreatic insulin secretion, revealing a possible new link in type 2 diabetes.
Read More »Good Care, Bigger Bills: The Hidden Cost of High-Deductible Diabetes Plans
Learn why high-deductible health plans increase out-of-pocket costs for diabetes care and what these expenses mean for patients and providers.
Read More »A New DME Drug Matched Anti-VEGF on Vision: Could Retina Care Be Ready for a New Option?
Discover how remigromig performed against anti-VEGF therapy in the BRUNELLO trial and what AAO 2026 findings mean for diabetic macular edema care.
Read More »The Immune Target Moved, but the Diabetes Didn’t: What a Failed Type 1 Trial Can Teach Us
Interleukin-2 boosted immune cells but failed to preserve insulin production in the DIABIL-2 trial. Discover what this means for type 1 diabetes.
Read More »